Navigation Links
UC Riverside to host conference on stricter air quality standards for Southern California
Date:5/2/2008

RIVERSIDE, Calif. How Southern California tackles the daunting task of meeting stricter federal and state emissions standards and reducing greenhouse gases is the focus of an all-day conference hosted by UC Riversides Edward J. Blakely Center for Sustainable Suburban Development and the Southern California Association of Governments (SCAG).

Clearing the Air: Issues and Strategies for Future Progress will be held on Thursday, May 22, from 7:30 a.m. to 4:30 p.m. at the Historic Mission Inn in downtown Riverside.

The conference will bring together academic, government, and economic leaders to examine the effects of emissions on health, address the challenges of meeting emissions standards to the goods movement industry, and explore potential solutions to future air quality issues.

Despite significant progress in the last 30 years, there is growing evidence that air pollutants in Southern California including particulate matter smaller than 2.5 microns (PM2.5) are exposing Southern California residents to potentially serious health risks.

There is overwhelming consensus that immediate attention needs to be taken to reduce greenhouse gases, said Rick Burnham, assistant director of the Edward J. Blakely Center for Sustainable Suburban Development. California has taken a leadership position to address global climate change with the promulgation of AB 32, legislation to reduce greenhouse gas emissions in California. Future federal and state emission standards for reducing air pollutants will require extreme challenges and new approaches to air quality planning in Southern California.

According to Mark Pisano, the former executive director of SCAG, Southern Californias current air quality management plan will not be able to meet these emission standards.

Some of these standards need to be met in less than a decade,
'/>"/>

Contact: Rick Burham
Rick.burnham@ucr.edu
951-827-4103
University of California - Riverside
Source:Eurekalert

Page: 1 2

Related biology news :

1. Chemicals used as fire retardants could be harmful, UC-Riverside researchers say
2. UC-Riverside partners with Chinese university to address Chinas environmental problems
3. UC Riverside biologist receives prestigious MacArthur Fellowship
4. Aware Announces Q1 2008 Earnings Conference Call
5. Energy Crossroads conference April 30 and May 1 at Stanford University
6. BIO-key(R) to Showcase Biometric Identification Technology at 2008 RSA Conference
7. ESF conference probes waters mysterious interactions at molecular level
8. American Society for Horticultural Science Annual Conference
9. BIO-key(R) to Showcase Biometric Identification Technology at 2008 RSA Conference
10. iPlant Kickoff Conference at CSHL begins tackling plant biologys grand challenges
11. Brown hosts regional bioengineering conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...already spurred public health officials to advise ...ing concern in a warmer world. , So suggests a p... Oecologia . , Sue Natali, a postdoctoral assoc...e paper,s lead author, compared mercury levels in ...bon dioxide to soil beneath trees in ambient air. ...
(Date:1/7/2009)...l issue of American Journal of Medical Genetics (... a comprehensive overview of the latest progress i...ity Disorder (ADHD). The issue covers major trends...erscoring how genetic studies of ADHD have evolved...netic origins. , ADHD is a complex condition wit...
(Date:1/7/2009)...sed to low temperatures develop more blood vessels...ore quickly, according to a new study from Karolin...o control blood vessel development in humans in or... of fat cells and their metabolism depend on oxyge...ulate the amount of body fat in order, for instan...
(Date:1/7/2009)... , A PhD thesis at the University of the Bas...e mutation that causes Fatal Familiar Insomnia (FF...try there is a high rate of carriers of this mutat...f Spain. , Fatal Familiar Insomnia (FFI) is o...ess than 100 cases described throughout the world....
Breaking Biology News(10 mins):To climate-change worries, add 1 more: Extended mercury threat 2To climate-change worries, add 1 more: Extended mercury threat 3Studies examine genetic determinants of ADHD 2Study on origin of mutation that causes fatal familiar insomnia 2Study on origin of mutation that causes fatal familiar insomnia 3Standard 26 Poors Announces Changes to U S Indices 22973 1Standard 26 Poors Announces Changes to U S Indices 22973 2Standard 26 Poors Announces Changes to U S Indices 22973 3Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 6313 1Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 6313 2Genmab Reaches Milestone in Ofatumumab Collaboration 2556 1Genmab Reaches Milestone in Ofatumumab Collaboration 2556 2Caffeine Could Stave Off Multiple Sclerosis 22968 1Caffeine Could Stave Off Multiple Sclerosis 22968 2
...tween researchers at the Salk Institute for Biolog...os Angeles captured the genome-wide DNA methylatio..."laboratory rat" of the plant world - in one big s... 20 years worth of anecdotal findings and then som...essor in the Salk Institute,s Plant Biology Labora...
...ns one of the deadliest threats to public health. ... which is caused by the microorganism Mycobacteriu...opulation is infected and more and more bacterial ...chers from the Hamburg Outstation of the European ...anck Institute for Infection Biology (MPIIB) in Be...
...versity research group has discovered that aggress...s critical to proper embryo formation. , An arti...n the advanced online issue of the journal Nature ...d highly unstable embryonic growth factor by injec...rafish embryos, which were used as "biosensors" fo...
...rs have discovered that the human immunodeficiency...vive efforts to destroy it by hiding out in the mu...at HIV continues to replicate in the gut mucosa, s...ed with antiretroviral therapy--even when blood sa...tment was working. Results of the three-year study...
Other Biology News:In a technical tour de force, Salk scientists take a global view of the epigenome 2In a technical tour de force, Salk scientists take a global view of the epigenome 3New potential drug target in tuberculosis 2Malignant melanoma cells secrete protein required for embryo formation 2UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery 2UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery 3
(Date:1/8/2009)... SAN DIEGO, Jan. 8 Orex...y announced that the first of four Phase 3 trials ...naltrexone sustained release,(SR)/bupropion SR) m...wing a,significant reduction in body weight, impr...ductions in selected food craving measures. , ...
(Date:1/8/2009)... REDWOOD CITY, Calif., Jan. 8 Ace...hired Dr. Roman Skowronski as Vice President, Clin...ronski will be responsible for,development and ex...l input,and review of clinical development strate...pany,s Chief Medical Officer. , Prior to jo...
(Date:1/8/2009)... HUNTINGTON BEACH, California, and AMSTERDAM, Jan... molecular cancer diagnostics, today announced the...mpany,s new Chief Financial,Officer. , "Ku...nvaluable asset,",said Bernhard Sixt, Ph.D., Pres...nsive financial management experience in the high ...
(Date:1/8/2009)...ERDEEN PROVING GROUND, Md., Jan. 8 ... anthrax attacks that followed, Edgewood Chemical ...ring Laboratory (EBML) staff focuses on developing...rld demands for global accreditation, increased se...y control. , , "We continue to work towards con...
Breaking Biology Technology:Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 2Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 3Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 4Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 5Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 6Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 7Agendia Appoints New Chief Financial Officer 2ECBC's Environmental BioMonitoring Laboratory Focuses on the Future 2ECBC's Environmental BioMonitoring Laboratory Focuses on the Future 3
... A few years ago, a VC friend of mine (that had ...repeatedly about a concept that was gathering forc...ction, in this case, meaning the casting away of p...ened to him and agreed, I didn,t recognize this mo...ing. The problem, as recognized by a recent articl...
... The transition from Microsoft Windows XP to ...the cultural transition we,ve already made from We...ly coined the term Web 2.0 in 2004, the Internet ... he imagined: a place where people are. It has bec...where we collaborate with others. It has also beco...
... West Allis, Wis. - Merge Healthcare , a financ...formation management software, continued to revamp...Bowers to president of Merge Healthcare North Amer...y,s senior vice president of strategic business in... Kenneth D. Rardin. In his new position, Bowers wi...
... Madison, Wis. - Molly Jahn is a realist, and sh...has a realistic chance to lead the drive toward en...f the College of Agricultural and Life Sciences ...ahn believes Wisconsin can leverage existing econo...uels. , ,She,s well aware of criticism that Wiscon...
Other Biology Technology:The deconstruction of Big Pharma 2The deconstruction of Big Pharma 3The deconstruction of Big Pharma 4The deconstruction of Big Pharma 5The deconstruction of Big Pharma 6The deconstruction of Big Pharma 7The deconstruction of Big Pharma 8Making the transition from Web 2.0 to Web 2.007 2Making the transition from Web 2.0 to Web 2.007 3UW-Madison dean predicts bio-economy will fuel Wisconsin 2UW-Madison dean predicts bio-economy will fuel Wisconsin 3
mCD-1 10 transcription reactions
Rabbits x 2 , Maintenance 112 days/each , Pre-immune bleed x1 /each , Immunizations/Boost injections x5 /each , Test bleed (app. 5 ml) x1 /each , Production bleed (25 ml blood =12 m
Mouse VCAM-1/CD106 MAb (Clone 112702)
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*
Biology Products: